Pneumococcal diseases in children in 1998

Vaccines: Children and Practice

Volumn 1, Issue 2, 1998, Pages 13-17

  Bégué, Pierre ^a  

^a ARMAND TROUSSEAU HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BETA LACTAM; CEFACLOR; CEFADROXIL; CEFATRIZINE; CEFIXIME; CEFOTAXIME; CEFPODOXIME; CEFTRIAXONE; CEFUROXIME; CEFUROXIME AXETIL; CEPHALOSPORIN DERIVATIVE; COTRIMOXAZOLE; ERYTHROMYCIN; MACROLIDE; OXACILLIN; PENICILLIN G; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE VACCINE; SULFAMETHOXAZOLE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BACTERIAL MENINGITIS; BACTERIAL PNEUMONIA; CAUSE OF DEATH; CHILD; CLINICAL FEATURE; CLINICAL TRIAL; DEVELOPING COUNTRY; DRUG EFFICACY; DRUG TOLERABILITY; HUMAN; IMMUNOGENICITY; INDUSTRIALIZATION; INFECTION CONTROL; MORBIDITY; MORTALITY; OTITIS MEDIA; PENICILLIN RESISTANCE; PRIORITY JOURNAL; SEPTICEMIA; SIDE EFFECT; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

EID: 1642401260     PISSN: 14606887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Gray BM, Dillon HC. Clinical and epidemiologic studies of pneumococcal infections in children. Pediatr Infect Dis 1986; 5: 201-7
2. Henderson FW, Gilligan PH, Wait K, et al. Nasopharyngeal carriage of antibiotic-resistant pneumococci by children in group day care. J Infect Dis 1988; 157: 256-63
3. Denoyelle F, Garabedian EN, Roelly P, et al. Protracted acute otitis media and acute mastoiditis: a prospective study of 165 cases. Ann Otol Rhinol Laryngol 1991; Suppl. 164: 264-7
4. Shann F. Etiology of severe pneumonia in children in developing countries. Pediatr Infect Dis 1986; 5: 247-52
5. Luzod N, Laupland K, Karan T, et al. Clinical features of invasive pneumococcal infection in children [abstract K99]. 37th Interscience Conference on Antimicrobial Agents and Chemotherapy: 1997 Sept 28 - Oct 1; Toronto: 345
6. Olivier C, Thibault H, Cohen R, et al. Twenty-three 3rd generation cephalosporin resistant S. pneumoniae meningitis in children in France, 1995, What is the issue? [abstract K83]. 37th Interscience Conference on Antimicrobial Agents and Chemotherapy: 1997 Sept 28 - Oct 1; Toronto: 342
7. Davies HD, Laupland K, Kellner J, et al. Outcome of invasive pneumococcal infections in hospitalized children [abstract K98]. 37th Interscience Conference on Antimicrobial Agents and Chemotherapy: 1997 Sept 28 - Oct 1; Toronto: 345
8. Hansman D, Bullen MM. A resistant pneumococcus. Lancet 1967; 2: 264-5
9. Appelbaum PC, Bhamjee A, Scragg JN, et al. Streptococcus pneumoniae resistant to penicillin and chloramphenicol. Lancet 1977; 2: 995-7
10. Merolla R, Ronchetti R, Chouang J, et al. Changing patterns of antimicrobial susceptibility of Streptococcus pneumoniae in Italy [abstract C43]. 37th Interscience Conference on Antimicrobial Agents and Chemotherapy: 1997 Sept 28 - Oct 1; Toronto: 53
11. Torres L, Pelaez T, Vasalle F, et al. Evolution of antibiotic resistance of Streptococcus pneumoniae: increase of penicillin resistance in blood and cerebrospinal fluid isolates [abstract C168]. 37th Interscience Conference on Antimicrobial Agents and Chemotherapy: 1997 Sept 28 - Oct 1; Toronto: 75
12. Weber M, Roussel-Delvallez M, Laurans G, et al. Enquêtes épidémiologiques régionales sur la ré sistance aux antibiotiques de S. pneumoniae: résultats pré liminaires de 6 observatoires régionaux. Med Mal Infect 1997; 275: 7-15
13. Mason EO, Lamberth LB, Kershaw NL, et al. S. pneumoniae antibiotic susceptibility in the United States: 1996-1997 [abstract E48]. 37th Interscience Conference on Antimicrobial Agents and Chemotherapy: 1997 Sept 28 - Oct 1; Toronto: 122
14. Frick P, Black D, Duchin J, et al. Prevalence of antimicrobial drug-resistant Streptococcus pneumoniae in Washington state [abstract E51]. 37th Interscience Conference on Antimicrobial Agents and Chemotherapy: 1997 Sept 28 - Oct 1; Toronto: 122
15. Song JM, Asian Network for Surveillance of Resistant Pneumococci Study Group. Prevalence of drug-resistant pneumococci in 11 Asian countries [abstract C48]. 37th Interscience Conference on Antimicrobial Agents and Chemotherapy: 1997 Sept 28 - Oct 1; Toronto: 54
16. Berezin EN, Brandileone MC, Casagrande S, et al. Invasive infections by Streptococcus pneumoniae in S. Paulo Brasil. Prevalence of penicillin nonsusceptible strains and serotypes [abstract K91]. 37th Interscience Conference on Antimicrobial Agents and Chemotherapy: 1997 Sept 28 - Oct 1; Toronto: 343-4
17. Voss L, Lennon D, Okesene-Gafa K, et al. Invasive pneumococcal disease in a pediatric population, Auckland, New Zealand. Pediatr Infect Dis J 1994; 13: 873-8
18. Foster JA, McGowan KL. Rising rate of pneumococcal bacteria at the children's hospital of Philadelphia. Pediatr Infect Dis J 1994; 13: 1143-4
19. Geslin P, Fremaux A, Sissia G, et al. Epidémiologie de la résistance de Streptococcus pneumoniae en France. Réseau national de surveillance (1984-1993). Med Mal Infect 1996; 24 (Spec Issue Oct): 948-61
20. American Academy of Pediatrics. Committee on infectious diseases. Therapy for children with invasive pneumococcal infections. Pediatrics 1997; 99: 289-99
21. Société de Pathologie Infectieuse de Langue Française. 9ème Conférence de Consensus en Thérapeutique Anti-infectieuse. Les méningites purulentes communautaires. Med Mal Infect 1996; 26 (Suppl, Fev): 1-8
22. Société de Pathologie Infectieuse de Langue Française. 10ème Conférence de Consensus en Thérapeutique Anti-infectieuse. Les infections ORL. Med Mal Infect 1996; 26 (Suppl. Juin): 1-7
23. Dagan R, Abramson O, Leibovitz E, et al. Impaired bacteriologic response to oral cephalosporins in acute otitis media caused by pneumococci with intermediate resistance to penicillin. Pediatr Infect Dis J 1996; 15: 980-5
24. MacLeod CM, Heideberger M, Hodges RG, et al. Prevention of pneumococcal pneumonia by immunization with specific capsular polysaccharides. J Exp Med 1945; 82: 445-65
25. Lawrence EM, Edward KM, Schiffman G, et al. Pneumococcal vaccine in normal children. Primary and secondary vaccination. Am J Dis Child 1983; 137: 846-50
26. Shapiro ED, Berg AT, Austrian R, et al. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med 1991; 325: 1453-60
27. Gaillat J, Zmirou D, Mallaret M, et al. Clinical trial of an antipneumococcal vaccine in elderly subjects living in institutions. Rev Epidemiol Sante Publique 1985; 33: 437-44
28. Fine MJ, Smith CA, Carson CA, et al. Efficacy of pneumococcal vaccination in adults. A meta-analysis of randomized controlled trials. Arch Intern Med 1994; 154: 2666-77
29. Giebink GS. Preventing pneumococcal disease in children: recommendations for using pneumococcal vaccine. Pediatr Infect Dis 1985; 4: 343-8
30. Riley ID, Alpers MP, Gratten H, et al. Pneumococcal vaccine prevents death from acute lower respiratory tract infections in Papua New Guinean children. Lancet 1986; 2: 877-81
31. Ahman H, Kaÿhty H, Lehtonnen H, et al. Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid conjugate vaccine is immunogenic in early infancy and able to induce immunologic memory. Pediatr Infect Dis J 1998; 17: 211-16
32. Leach A, Ceesay CJ, Banaya WA, et al. Pilot trial of a pentavalent pneumococcal polysaccharide protein conjugate vaccine in Gambian infants. Pediatr Infect Dis J 1996; 15: 333-9
33. Bégué P, Grimprel E. Mortality during acute bacterial infections of lower respiratory tract in children. Pediatr Pulmonol 1995; 11: 14-15
34. Peter G, Klein JO. Pneumococcal vaccine. Pediatr Rev 1996; 17: 335-41